MedTrace Logo

Effectiveness of A Hemodynamic-Guided Treatment Strategy to Improve Blood Pressure Control

NCT04715698 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2021-01-20

No results posted yet for this study

Summary

A single-center, single-blind, randomized study to investigate the effectiveness of a hemodynamic-guided treatment strategy to improve blood pressure control

Conditions

Interventions

OTHER

ICG-guided drug selection

anti-hypertensive drug selection based on patient's hemodynamic profiling and physician's experience

OTHER

empirical drug selection

anti-hypertensive drug selection based on physician's experience only

Sponsors & Collaborators

  • Yale University

    collaborator OTHER

  • Shanghai Jiao Tong University School of Medicine

    collaborator OTHER

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Ningling Sun · Department of Hypertension at Heart Centr, Peking University People's Hospital, Beijing, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-31
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04715698 on ClinicalTrials.gov